v3.26.1
Derivative and Hedging Activities - Location and Amount of Gain (Loss) in Income on Fair Value and Cash Flow Hedging Relationships (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Location, Statement of Income, Balance [Axis]: us-gaap:InterestAndDividendIncomeOperating        
Derivative Instruments, Gain (Loss) [Line Items]        
Total amounts of income and expense line items presented in the consolidated statements of income in which the effects of fair value or cash flow hedges are recorded $ 8 $ 536 $ 51 $ 1,086
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Interest Income (Expense), Operating Interest Income (Expense), Operating Interest Income (Expense), Operating Interest Income (Expense), Operating
Location, Statement of Income, Balance [Axis]: us-gaap:InterestAndDividendIncomeOperating | Interest Rate Contract, Hedged Items [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
The effects of fair value and cash flow hedging: $ (284) $ 2,118 $ (412) $ 6,696
Location, Statement of Income, Balance [Axis]: us-gaap:InterestAndDividendIncomeOperating | Interest Rate Contract [Member] | Designated as Hedging Instrument [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
The effects of fair value and cash flow hedging: 284 (2,054) 412 (6,588)
Location, Statement of Income, Balance [Axis]: us-gaap:InterestAndDividendIncomeOperating | Interest Rate Contract [Member] | Designated as Hedging Instrument [Member] | Fair Value Hedging [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount excluded from effectiveness testing recognized in earnings based on amortization approach 0 0 0 0
Location, Statement of Income, Balance [Axis]: us-gaap:InterestAndDividendIncomeOperating | Interest Rate Contract [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain or (loss) reclassified from accumulated other comprehensive income into income 0 (0) (0) (0)
Amount excluded from effectiveness testing recognized in earnings based on amortization approach 0 0 0 0
Location, Statement of Income, Balance [Axis]: us-gaap:InterestExpenseOperating        
Derivative Instruments, Gain (Loss) [Line Items]        
Total amounts of income and expense line items presented in the consolidated statements of income in which the effects of fair value or cash flow hedges are recorded $ 311 $ 723 $ 721 $ 1,473
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Interest Income (Expense), Operating Interest Income (Expense), Operating Interest Income (Expense), Operating Interest Income (Expense), Operating
Location, Statement of Income, Balance [Axis]: us-gaap:InterestExpenseOperating | Interest Rate Contract, Hedged Items [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
The effects of fair value and cash flow hedging: $ 0 $ 0 $ 0 $ 0
Location, Statement of Income, Balance [Axis]: us-gaap:InterestExpenseOperating | Interest Rate Contract [Member] | Designated as Hedging Instrument [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
The effects of fair value and cash flow hedging: 0 0 0 0
Location, Statement of Income, Balance [Axis]: us-gaap:InterestExpenseOperating | Interest Rate Contract [Member] | Designated as Hedging Instrument [Member] | Fair Value Hedging [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount excluded from effectiveness testing recognized in earnings based on amortization approach 0 0 0 0
Location, Statement of Income, Balance [Axis]: us-gaap:InterestExpenseOperating | Interest Rate Contract [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain or (loss) reclassified from accumulated other comprehensive income into income 310 124 501 211
Amount excluded from effectiveness testing recognized in earnings based on amortization approach $ 0 $ 0 $ 0 $ 0